Amedica and Zimmer soon to be one

Discussion in 'Zimmer' started by Boston745, Sep 20, 2017 at 12:18 PM.

?

How long until Zimmer acquires Amedica?

  1. 1 month

  2. End of year

  3. 2018

  4. 2019

  5. Never

Results are only viewable after voting.
  1. Boston745

    Boston745 Guest

    Amedica has been under contract since 2015 likely with no shop clause that prevents those other suitors from coming in. Not just that, but Sonny's loan sets up another level of protection that would prevent hostile acquisition of assets. Google "crown jewels" as an anti-takeover protection mechanism. North stadium is friendly 3rd party with claim to all assets.
     

  2. anonymous

    anonymous Guest

    You do realize your a moron
     
  3. anonymous

    anonymous Guest

    I'll google it next year, too busy now with holudays.Yawn I'm tired, bye.
     
  4. Boston745

    Boston745 Guest

    "You're". Better not be an idiot if your gonna call people a moron.
     
  5. anonymous

    anonymous Guest

    Bryan Hanson was part of the medtronic team that came back laughing at what Amedica had to say. Now that he has landed at Zimmer it looks doubtful that he would want to fund the studies that Medtronic told Amedica they needed to do regarding silicone nitrate. Amedica hasn't done anything except keeping up with "superior results" talk and still afraid of paying for real studies for some reason. Either they have no money to do any studies or they are afraid of results that will follow. FDA wants studies also from them yet they still fail to acknowledge that fact.
     
  6. CL101

    CL101 Guest

    AMDA is a biomaterial company. Their magical Si3N4 tech can penetrate many types of market (Shoulders, Ankles, Spines, Knees, Hips, Dental, 3D Printing, Metal Brazing, Non-Medical Applications)...In addition, Japan Clearance + Huge Deals coming, Pending CFDA (a couple 100K units deal signed), plus 200mils + NOL (accumulated tax loss), etc...
     
  7. anonymous

    anonymous Guest

    Nailed it! Hanson can't stand Dr. Bal at Amedica.
     
  8. CL101

    CL101 Guest

    No lapse time between resignation at MDT & acceptance as CEO at ZBH ... especially right at the holiday season. Why so rush? Looks like they wanted him to take over the CEO position asap to sign some important documents. Notified MDT on 18th & on the 19th = officially ZBH CEO...lmao...He actually gave MDT a middle finger.
    1. Meticulous Preparations & Plans = New Spine HQ in Colorado, Loan in Japan, etc...
    2. Vast Personnel Resources & Huge Worldwide Operations
    "As of December 31, 2016, we employed approximately 18,500 employees worldwide, including approximately 2,000 employees dedicated to research and development. Approximately 8,700 employees are located within the U.S. and approximately 9,800 employees are located outside of the U.S., primarily throughout Europe and in Japan. We have approximately 7,800 employees dedicated to manufacturing our products worldwide. The Warsaw, Indiana production facilities employ approximately 2,600 employees in the aggregate."
    3. Leadership Teams (New CEO & Pending announcement of Spine President (Dana, Long, etc..?)
    Zimmer previous CEO David resigned = stock surged = Fraud St. loves the news:
    4. Acquiring new, superior tech like AMDA's Si3N4!
    5. Excellency in Plans Executions
    Putting Bezos, Gates, Buffet, Page, etc... to work together w/ the the new CEO Bryan...there won't be much growth down the road if they don't have a super tech like Si3N4 from AMDA as their attack weapon to help to gain market shares from many potential product types (from Si3N4 biomaterial). In conclusion, it must be a coaction of at least 5 above factors to make things work.
    AMDA is a biomaterial company. Their magical Si3N4 tech can penetrate many types of market (Shoulders, Ankles, Spines, Knees, Hips, Dental, 3D Printing, Metal Brazing, Non-Medical Applications)...In addition, Japan Clearance + Huge Deals coming, Pending CFDA (a couple 100K units deal signed), plus 200mils + NOL (accumulated tax loss), etc...
    I believe the BO valuation will be very interesting & I can't wait to read the details of the deal. These guys will make sure the BO price will be fair & square:
    Also, their IPR&D valuation should be enormous based on the addressable market potential. Check Boston's blog to see crazy addressable market size of the tech in details. Just google ... you will find the same public info Boston found.
     
  9. anonymous

    anonymous Guest

    All we at amedica wanted for christmas was the ego maniac Dr. Bal to be fired and some leadership that doesnt try to intimidate anyone with ideas. If this is true I hope Zimmer fires Bal and the rest of the clowns he brought in recently to secure his position as long as possible. Moral is lowest ever and most of us have started looking for jobs elsewhere. Don't believe me stop by the puck sometime and you will find some of us talking about the what ifs of Amedica.
     
  10. anonymous

    anonymous Guest

    medtronic gonna buy Zimmer. Zimmer last 2 quarters were bad, so will this next one. Sale sign in the window and Hanson will make this smooth like the Cov merger.
     
  11. anonymous

    anonymous Guest

    You’re a complete moron! Listen jerk off..if “you’re” technology was so “great” YOU would not be here on this stupid gossip board trying to sell it! Seriously douche! Get a clue! Do you enjoy sucking cock? A
     
  12. Boston745

    Boston745 Guest

    You will have your foot in your mouth when you have no choice but to sell Si3N4 total joints because it has taken over the spine industry. Do you enjoy not being right? Accept your fate.
     
  13. CL101

    CL101 Guest

    PEEK boy Medtronic has ZERO chance to lay their hands on AMDA's Si3N4 tech. If you really looked into Boston's blog, you will see Zimmer's finger prints are all over AMDA & Si3N4 tech. AMDA is technically Zimmer's little b*tch & only want to date & to marry Zimmer ONLY! Medtronic looked at Si3N4 and passed??? LMFAO! Biggest joke ever! It's more like Zimmer looked at PEEK & RAN for the hills:
     
  14. anonymous

    anonymous Guest

    Keep in mind that CL101, Atlanta and a few others are aliases used by Boston745.
     
  15. anonymous

    anonymous Guest

    Aggressive stock promotion. Exercise extreme caution if there appears to be greater promotion of the company’s stock than of the company’s products or services.

    Guaranteed high investment returns. Be highly suspicious if the promoter promises you a high rate of return on your investment.

    https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html
     
  16. anonymous

    anonymous Guest

    The rumor I heard last week was that Amedica was headed for bankruptcy as they ran out of money and can't pay debts. Looks like they are printing shares and begging for more investors to keep doors open again
     
  17. anonymous

    anonymous Guest

    Bankruptcy is close. If this was anything it would have been scooped up by anyone for pennies on the dollar by now. Not even arthrex who wants a total joint advantage, an anchor andvantage ect wants this pos. Company needs real 3rd party research and white papers that can't be argued. All fluff for now.
     
  18. anonymous

    anonymous Guest

    Roflmao talk about misinformation.
     
  19. anonymous

    anonymous Guest

    Misleading Information - FALSE Rumor - More illegal activities from white collar thieves (Market Makers, Hedge Funds/Shorts) to orchestrate attacking on share price before acquisition.

    Hey Yahoos...If you want to talk about AMDA stock please go to here:

    https://investorshub.advfn.com/Amedica-Corp-AMDA-27931/


    This Zimmer board is for discussion of products/techs/workplace issues/managments related topics...Medtronic rep., Stryker rep., Depuy rep., etc...are you yahoo worry that Zimmer is getting a killer weapon soon?

    BTW...look at all the following FACT:

    Zimmer Biomet (NYSE:ZBH) Q4 2017 Earnings Conference Call January 30, 2018 8:00 AM ET, Bryan Hanson CEO excerpt:

    "In terms of our innovation capabilities, Zimmer Biomet is uniquely positioned to leverage platform technologies across our entire portfolio, including advanced proprietary materials and surgical robotics applications. As a company, we plan to build on this foundation. We will have an unwavering emphasis on patient safety and quality excellence, creating an engaged and innovative workplace and working to position the company to deliver top quartile total shareholder returns."

    https://seekingalpha.com/article/4141232-zimmer-biomets-zbh-ceo-bryan-hanson-q4-2017-results-earnings-call-transcript?part=single

    So obviously he wasn't talking about metal material:

    https://www.massdevice.com/zimmer-biomet-loses-bid-dismiss-metal-metal-hip-cases/

    http://www.telegraph.co.uk/news/2017/10/25/depuy-hip-replacement-safety-tests-seriously-flawed-high-court/

    and of course it was not about ZTA too:

    1. https://ibb.co/e3Ymvn

    2. https://ibb.co/bGiKFn

    https://www.hindawi.com/journals/crior/2014/837954/

    http://evertsmith.com/innovations/#head

    You see that pink golf ball? Zimmer is trying to toss it out & replaces it with the better "advanced propietary materials":

    Recently updated on their website:

    "Some of these chemicals may tend to corrode some materials. In order for an implant to perform under these conditions, it must be made from materials that can withstand these forces and chemical environment in the patient.

    Whether an implant is designed to replace a joint, or help repair a fracture, several physical and biological characteristics are important when selecting the material for the implant. For example, an implant must be sufficiently strong, flexible, and resistant to wear. But that doesn’t mean the strongest material, or the most flexible material, is the best material."

    The ideal implant material should have physical characteristics that match those of the bone it is replacing or reinforcing.

    http://www.zimmerbiomet.com/patients-caregivers/article/hip/implants-made-of.html

    Less Weight Decrease, which leads to less corrosive compares to Ziconia

    https://global.kyocera.com/fcworld/charact/chemistry/chemiresist.html

    http://www.ijmse.net/uploadfile/2016/0715/20160715041827481.pdf
    (Look at the table on Page 120 - Higher Fracture Toughness than gold standard ZTA!)

    Less wear compares to gold standard:

    As previously announced, Amedica completed five million cycle (Mc) wear testing of silicon nitride femoral heads in comparison to the industry-standard zirconia-toughened alumina (ZTA). Silicon nitride produced less wear, and less oxidative damage to the polyethylene than ZTA. Testing is continuing through 12 million cycles. Additional testing of the corrosion resistance of silicon nitride femoral heads is in progress toward a regulatory filing.

    completed a five million cycle (Mc) comparative hip simulator study examining the wear behavior of an advanced highly cross-linked and vitamin E stabilized polyethylene (E1® Zimmer-Biomet, Warsaw, IN, USA) against two different types of ceramic femoral heads

    https://finance.yahoo.com/news/amedica-announces-results-independent-femoral-140000421.html

    5 Millions wear rate testing is for FDA submission:

    A tribological study of the BHR was conducted to analyze volumetric wear rates for 5 million
    cycles. The study used a hip joint simulator to compare the volumetric wear rates of five devices
    subjected to dynamic loads and motions and one control specimen that was dynamically lo<ided
    but experienced no tangential motions.

    https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040033b.pdf

    Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017. If the tests indicate that silicon nitride femoral heads are superior in terms of wear performance, taper corrosion, strength and in vitro hydrothermal stability, we eventually intend to commercialize this product in cooperation with a strategic partner

    We are seeking a strategic partner to develop and commercialize our total joint replacement product candidates. We will be reliant on our strategic partners to develop and commercialize a total hip or knee joint replacement product candidate that utilizes silicon nitride-coated components, although we have not yet entered into an agreement with any strategic partner to develop products with these silicon nitride-coated components and may be unable to do so on agreeable terms. In order to succeed in our joint commercialization efforts, we and any future partners must execute effectively on all elements of a combined business plan, including continuing to establish sales and marketing capabilities, manage certified, validated and effective commercial-scale manufacturing operations, conduct product development and testing, and obtain regulatory clearances and approvals for our product candidate.

    https://www.sec.gov/Archives/edgar/data/1269026/000149315218002146/forms-1.htm

    Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.

    http://spineblogger.blogspot.com/2011/05/whos-next.html?m=1

    Years of planning & they needed time to further validate the Si3N4 technologies. They didn't plan this yesterday!!! Based on Hanson's wordings in 4Q CC...trigger pulling soon!

    Currently, a few Zimmer VPs at Amedica:

    https://www.linkedin.com/in/ryanjlong/

    https://www.linkedin.com/in/jamey-rottman/

    https://www.linkedin.com/in/dana-lyons-a23b9550/

    & might be more in other regions...esp. international like EU & ASIA (Japan)
     
  20. anonymous

    anonymous Guest

    The average burst test strength for the silicon nitride femoral heads in these tests was 75 kilonewtons, or kNs, compared with 65 kN for BIOLOX® delta, or about a 15% improvement.

    https://www.sec.gov/Archives/edgar/data/1269026/000149315218002146/forms-1.htm

    In the body, alumina and ZTA both release oxygen ions, which can degrade polyethylene bearings [49,65]. Silicon nitride is unique in that it is a non-oxide ceramic, which means not only is it stronger and tougher than alumina and ZTA [9], it also absorbs oxygen away from polyethylene [66,67]. This remarkable property could take hip and knee replacements into the third and fourth decades of service, something that is only a speculation today.

    http://www.opnews.com/2016/11/the-story-of-silicon-nitride/13077

    "Testing is continuing through 12 million cycles" (5 million cycles for FDA - Further testing to validate their findings)

    https://finance.yahoo.com/news/amedica-announces-results-independent-femoral-140000421.html

    Si3N4 - Help Zimmer to develop Knee products also:

    A metal-ceramic brazing project with a global ceramics manufacturer is underway, targeting the total knee market, and composite devices in the spine market.

    (For Hip replacement - Metal brazing can create a [CSC] - cancellous structured ceramic coating on the external of stems & cups, to promote healthier bone growth formation. Look at page 15 for their 2nd Gen Si3N4)

    https://seekingalpha.com/article/4110015-amedica-amda-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow

    The company is testing the friction and wear behavior of polished silicon nitride against native cartilage. If successful, this project will open hemi-arthroplasty applications in several anatomic joint reconstructions, where native cartilage is partially preserved.

    https://www.amedica.com/news-media/press-releases/detail/100/correction---amedica-releases-2016-preliminary-unaudited

    We have developed a femoral condyle design made from our solid silicon nitride. The femoral condyle component will attach to the lower end of the femur. The femoral condyle is expected to articulate against a cross-linked polyethylene tibial insert that will attach to the tibial tray at the upper end of the tibia, which we expect will be made from metal. We have successfully made prototypes of this design. Following the potential clearance of the femoral head components (discussed above), we intend to initiate biomechanical testing with a strategic partner for silicon nitride components for use in knee replacement procedures to support a 510(k) submission to the FDA. If this clearance is eventually obtained, we intend to commercialize our products for use in total knee replacement surgeries post-FDA clearance.

    https://www.sec.gov/Archives/edgar/data/1269026/000149315218002146/forms-1.htm

    Spine as well - perfectly clicked with Hanson' sworn to focus on safety & quality aspects for patients:

    Results from Amedica's CASCADE clinical trial showing effective spine fusion with porous silicon nitride without added bone graft are now published in the European Spine Journal. A similar trial (SNAP) compared silicon nitride to PEEK in lumbar fusion; preliminary data from the SNAP trial are consistent with previous observations that silicon nitride shows enhanced and earlier spine fusion than PEEK.

    https://www.amedica.com/news-media/press-releases/detail/100/correction---amedica-releases-2016-preliminary-unaudited

    https://link.springer.com/article/10.1007%2Fs00586-017-5079-6

    Again...HANSON SAID: "Patients' safety and quality" - Si3N4 CSC pourous silicon (once the tech owned by Zimmber, FDA sure will approve it later) has the solutions for issues like below:

    1. Eliminate autograft

    Bone Graft Site Pain and Morbidity After Spinal Fusion

    https://www.spine-health.com/treatment/spinal-fusion/bone-graft-site-pain-and-morbidity-after-spinal-fusion

    What is next?

    2. Eliminate allograft

    Risk of disease transmission. Despite rules and regulations for tissue banks regarding processing and procedures of human tissue, there is still a small potential risk of disease transmission from using cadaver bone.

    https://www.spine-health.com/treatment/spinal-fusion/allograft-cadaver-bone-a-tissue-bank

    What is next?

    3. Elminate Synthetic Bone - Infuse issues:

    https://www.baumhedlundlaw.com/defective-medical-device-injuries/medtronic-infuse-bone-graft-device-lawsuit/

    https://www.medpagetoday.com/surgery/orthopedics/28569

    https://www.gomn.com/news/senate-panel-says-medtronic-manipulated-articles-to-tout-spine-products

    http://www.startribune.com/judge-allows-class-action-suit-over-medtronic-s-infuse-product-to-proceed/472257183/

    http://www.startribune.com/question-of-risk-medtronic-s-lost-infuse-study/372957441/

    http://www.startribune.com/medtronic-says-failure-to-report-infuse-data-was-unintentional/380049991/

    https://www.bizjournals.com/twincities/news/2017/06/29/medtronic-could-soon-settle-thousands-of-infuse.html

    https://www.raps.org/news-articles/news-articles/2017/12/medtronic-settles-deceptive-advertising-lawsuit-for-$12m

    Can you yahoos - white collar thieves - see how profitable Zimmer will be later after owing Si3N4 technologies from Amedica? Also, don't forget Hanson QUITTED his last job at medtronic in December 2017.

    The bonuses for Zimmer & again go against head to head with metal (Titanium) and oxide ceramic (Zirconia):

    For decades titanium has been the preferred material for dental implant fabrication, with mechanical and biological performance resulting in high clinical success rates. These have been further enhanced by incremental development of surface modifications aimed at improving speed and degree of osseointegration and resulting in enhanced clinical treatment options and outcomes. However, increasing demand for metal-free dental restorations has also led to the development of ceramic-based dental implants, such as zirconia. In orthopedics, alternative biomaterials, such as polyetheretherketone or silicon nitride, have been used for implant applications. The latter is potentially of particular interest for oral use as it has been shown to have antibacterial properties. In this article we aim to shed light on this particular biomaterial as a future promising candidate for dental implantology applications, addressing basic specifications required for any dental implant material. In view of available preclinical data, silicon nitride seems to have the essential characteristics to be a candidate for dental implants material. This novel ceramic has a surface with potentially antimicrobial properties, and if this is confirmed in future research, it could be of great interest for oral use.

    https://www.ncbi.nlm.nih.gov/pubmed/28301307

    & Non-medical applications revenue streams as well.

    It's all about biomaterial!